HIMSSCast: The future of telehealth reimbursement
Limits and uncertainty all over telehealth reimbursement have normally been an impediment to adoption. For the duration of the COVID-19 unexpected emergency, that load was eased somewhat, but now the new usual is starting to get form. What obstacles still continue being to telehealth reimbursement, and how may well they be conquer? To reply that query, host Jonah Comstock and Healthcare Finance Information Running Editor Susan Morse welcome McKinsey & Company companions Oleg Bestsennyy and Gunjan Khanna.
This episode is introduced to you by BlueJeans.
Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Participate in!
Conversing factors:
- COVID-19 reimbursement changes and which of them will stick all over
- Adoption lessons acquired and how they’ll affect reimbursement coverage
- Holistic tele-care and care further than the online video go to
- Influence of new entrants and innovation on the space
- Is fee-for-assistance reimbursement an innovation blocker?
- Reimbursement for distinctive telehealth modalities
- Time to lead relatively than observe for personal payers?
- The still-unresolved query of induced utilization
- The rise of worth-based care and hybrid care designs
- Telehealth reimbursement and health fairness
- How are individuals experience about telehealth now?
- Remaining views: the foreseeable future of telehealth reimbursement
A lot more about this episode:
Report exhibits ‘vast improvement’ in state telehealth reimbursement procedures
COVID-19 could forever alter the telehealth landscape, from reimbursement to utilization
Telehealth reimbursement parity spurs insurance provider fears of overutilization
CMS will reimburse for 11 new telehealth expert services through the community health unexpected emergency
Congressional action is needed for telehealth not to return to a rural reward, Seema Verma suggests
Telehealth: A quarter-trillion-greenback publish-COVID-19 fact? (McKinsey)
COVID-19 Customer Healthcare Insights: What 2021 could hold (McKinsey)
How COVID-19 has modified the way US consumers consider about healthcare (McKinsey)
